Background MicroRNAs (miRNA) have potential as prognostic biomarkers and therapeutic
targets in cancer. A study was undertaken to investigate the association between miRNA …

Abstract The microRNAs (miRNAs), miR-194 and miR-29b, have been shown to
downregulate in colorectal cancer (CRC) and may identify and classify CRC patients as …

Background MicroRNAs (miRNAs) are effective regulators of gene expression that play a
pivotal role in the pathogenesis of colorectal cancer (CRC) and various other cancers. The …

OBJECTIVE: MicroRNAs (miRNAs) as a new class of biomarkers have been explored in
recent studies. We investigate whether miR-1256 could be considered as powerful …

Background MicroRNAs (miRNAs) regulate gene expression by binding to mRNA, and can
function as oncogenes or tumor suppressors depending on the target. In this study, using …

Background Patients with stage II CRC have a varying survival outcome. Therefore, it is
critical to identify prognostic biomarkers that can define more aggressive forms of the …

Background A series of studies have investigated the vital role of microRNA‐181 (miR‐181)
in the initiation and development of colorectal cancer (CRC), and demonstrated that it might …

Several microRNAs (miRNAs) are known to be deregulated in colon cancer, but the
mechanisms behind their potential involvement on proliferation and tumor cell survival are …

Recent studies have increasingly linked microRNAs to colorectal cancer (CRC). MiR-194
has been reported deregulated in different tumor types, whereas the function of miR-194 in …

Despite recent advances in diagnosis and treatment, colorectal cancer (CRC) remains the
third most common cancer worldwide, and has both a poor prognosis and a high recurrence …